{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:17:34Z","timestamp":1773955054754,"version":"3.50.1"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cellimm.2019.104021","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T02:11:35Z","timestamp":1573870295000},"page":"104021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus"],"prefix":"10.1016","volume":"347","author":[{"given":"Atsushi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick S.C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2019.104021_b0005","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0010","doi-asserted-by":"crossref","first-page":"25906","DOI":"10.1038\/srep25906","article-title":"Evolving Trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2019.104021_b0015","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13342","article-title":"Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan","author":"Tanaka","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cellimm.2019.104021_b0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12016-017-8656-x","article-title":"Geoepidemiology of primary biliary cholangitis: lessons from Switzerland","volume":"54","author":"Terziroli Beretta-Piccoli","year":"2018","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12016-016-8583-2","article-title":"The management of autoimmune hepatitis patients with decompensated cirrhosis: real-world experience and a comprehensive review","volume":"52","author":"Wang","year":"2017","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.10.015","article-title":"The immunobiology of female predominance in primary biliary cholangitis","volume":"95","author":"Gerussi","year":"2018","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.livres.2017.12.002","article-title":"Primary sclerosing cholangitis: a review and update","volume":"1","author":"Tabibian","year":"2017","journal-title":"Liver Res."},{"key":"10.1016\/j.cellimm.2019.104021_b0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000333","article-title":"The evolution of natural history of primary sclerosing cholangitis","volume":"33","author":"Takakura","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaut.2018.10.024","article-title":"Prognostic models in primary biliary cholangitis","volume":"95","author":"Cristoferi","year":"2018","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.12.011","article-title":"A comprehensive evaluation for the treatment of lupus nephritis","volume":"78","author":"Zampeli","year":"2017","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0055","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/hepr.13364","article-title":"Liver Transplantation in Japan: registry by the Japanese liver transplantation society","author":"Umeshita","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cellimm.2019.104021_b0070","doi-asserted-by":"crossref","unstructured":"J.K. Dyson, U. Beuers, D.E.J. Jones, A.W. Lohse, M. Hudson, Primary sclerosing cholangitis, Lancet (London, England), 391 (2018) 2547-2559.","DOI":"10.1016\/S0140-6736(18)30300-3"},{"key":"10.1016\/j.cellimm.2019.104021_b0075","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/lt.25321","article-title":"Primary biliary cholangitis guidance update: implications for liver transplantation","volume":"24","author":"Levy","year":"2018","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellimm.2019.104021_b0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpg.2018.09.001","article-title":"PBC-transplantation and disease recurrence","volume":"34\u201335","author":"Nevens","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cellimm.2019.104021_b0095","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.cellimm.2019.104021_b0100","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaut.2018.10.020","article-title":"Etiopathogenesis of autoimmune hepatitis","volume":"95","author":"Floreani","year":"2018","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0110","article-title":"Standardization of autoantibody testing in autoimmune hepatitis","author":"Muratori","year":"2018","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-016-8579-y","article-title":"Challenges in the standardization of autoantibody testing: a comprehensive review","volume":"53","author":"Tozzoli","year":"2017","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"International Autoimmune Hepatitis, Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0130","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: Autoimmune hepatitis, J Hepatol, 63 (2015) 971-1004.","DOI":"10.1016\/j.jhep.2015.06.030"},{"key":"10.1016\/j.cellimm.2019.104021_b0135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.25658","article-title":"Long-term outcome of Japanese patients with type 1 autoimmune hepatitis","volume":"56","author":"Yoshizawa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0140","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/lt.25451","article-title":"Acute severe autoimmune hepatitis: corticosteroids or liver transplantation?","volume":"25","author":"Rahim","year":"2019","journal-title":"Liver Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0150","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0155","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cellimm.2019.104021_b0160","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","author":"Krishnamoorthy","year":"2016","journal-title":"Liver Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00007890-199907270-00016","article-title":"Recurrence of autoimmune hepatitis after liver transplantation","volume":"68","author":"Milkiewicz","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0175","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0180","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","author":"Montano-Loza","year":"2009","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0185","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0195","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/apt.13894","article-title":"Systematic review: recurrent autoimmune liver diseases after liver transplantation","volume":"45","author":"Montano-Loza","year":"2017","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.cellimm.2019.104021_b0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bpg.2017.04.004","article-title":"Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation","volume":"31","author":"Visseren","year":"2017","journal-title":"Best Pract Res. Clin. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0210","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2018.10.022","article-title":"Novel therapeutic targets in autoimmune hepatitis","volume":"95","author":"Taubert","year":"2018","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0215","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","article-title":"The clinical phenotypes of autoimmune hepatitis: a comprehensive review","volume":"66","author":"Wang","year":"2016","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0220","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hep.22435","article-title":"Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database","volume":"48","author":"Balan","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0225","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1053\/j.gastro.2015.08.031","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'","volume":"149","author":"Beuers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cellimm.2019.104021_b0230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol. Int."},{"issue":"2019","key":"10.1016\/j.cellimm.2019.104021_b0235","first-page":"394","article-title":"Practice guidance from the american association for the study of liver diseases","volume":"69","author":"Lindor","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.05.008","article-title":"Evolution of our understanding of PBC","volume":"34\u201335","author":"Tanaka","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12016-014-8449-4","article-title":"Women and primary biliary cirrhosis","volume":"48","author":"Sun","year":"2015","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","article-title":"Chronic autoimmune epithelitis in sjogren's syndrome and primary biliary cholangitis: a comprehensive review","volume":"4","author":"Selmi","year":"2017","journal-title":"Rheumatol. Ther."},{"key":"10.1016\/j.cellimm.2019.104021_b0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5114\/ceji.2016.60993","article-title":"Liver damage in primary biliary cirrhosis and accompanied by primary Sjogren's syndrome: a retrospective pilot study","volume":"41","author":"Zhu","year":"2016","journal-title":"Central-Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12016-015-8471-1","article-title":"The coexistence of Sjogren's syndrome and primary biliary cirrhosis: a comprehensive review","volume":"48","author":"Sun","year":"2015","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0265","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/14737159.2016.1164038","article-title":"A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis","volume":"16","author":"Leung","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.cellimm.2019.104021_b0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cld.2015.08.003","article-title":"Making sense of autoantibodies in cholestatic liver diseases","volume":"20","author":"Marzorati","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.cellimm.2019.104021_b0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0280","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2019.04.004","article-title":"Florid biliary duct lesions in an AMA -positive patient in absence of cholestatic liver biochemistry","volume":"101","author":"Sultan","year":"2019","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0285","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2152\/jmi.64.7","article-title":"Primary biliary cholangitis: its pathological characteristics and immunopathological mechanisms","volume":"64","author":"Tsuneyama","year":"2017","journal-title":"J. Med. Investig."},{"key":"10.1016\/j.cellimm.2019.104021_b0290","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.24355","article-title":"Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis","volume":"54","author":"Rong","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2018.01.007","article-title":"The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: regulation by cholic acid-induced Interleukin-7","volume":"90","author":"Jiang","year":"2018","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0305","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/746192","article-title":"Renal transplantation in systemic lupus erythematosus: outcome and prognostic factors in 50 cases from a single centre","volume":"2014","author":"Cairoli","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0310","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/hep4.1058","article-title":"Recurrence of primary biliary cholangitis after liver transplantation: a Japanese perspective","volume":"1","author":"Montano-Loza","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.cellimm.2019.104021_b0315","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/apt.15060","article-title":"Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades","volume":"49","author":"Harms","year":"2019","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.cellimm.2019.104021_b0320","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engld J. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0325","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"New Engld J. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30552","article-title":"Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis","author":"Honda","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0335","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/ajt.12132","article-title":"Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Carbone","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0340","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0350","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0355","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0360","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cei.13198","article-title":"Pathogen infections and primary biliary cholangitis","volume":"195","author":"Tanaka","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0370","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0375","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep4.1037","article-title":"Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: a Japanese multicenter retrospective study","volume":"1","author":"Kogiso","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.cellimm.2019.104021_b0380","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cld.2018.03.002","article-title":"The genetics and epigenetics of primary biliary cholangitis","volume":"22","author":"Tanaka","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.cellimm.2019.104021_b0385","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/liv.13686","article-title":"Primary biliary cholangitis in british columbia first nations: clinical features and discovery of novel genetic susceptibility loci","volume":"38","author":"Asuri","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0390","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.cellimm.2019.104021_b0395","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12016-015-8472-0","article-title":"Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population","volume":"48","author":"Dong","year":"2015","journal-title":"Clin. Rev. Aller. Immunol."},{"key":"10.1016\/j.cellimm.2019.104021_b0400","first-page":"650","article-title":"Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population","volume":"26","author":"Kawashima","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellimm.2019.104021_b0405","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.29603","article-title":"Genetic association studies and the risk factors for developing the \u201cImmuno-bile-logic\u201d disease primary biliary cholangitis","volume":"67","author":"Liaskou","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0410","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","author":"Ornolfsson","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0415","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12920-016-0239-9","article-title":"A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients","volume":"10","author":"Paziewska","year":"2017","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.cellimm.2019.104021_b0420","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1038\/ncomms14828","article-title":"A genome-wide association study identifies six novel risk loci for primary biliary cholangitis","volume":"8","author":"Qiu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2019.104021_b0425","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0430","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0435","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.28256","article-title":"Surrogate endpoints for clinical trials in primary sclerosing cholangitis: review and results from an International PSC Study Group consensus process","volume":"63","author":"Ponsioen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0440","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000751","article-title":"Long-term prognosis and recurrence of primary sclerosing cholangitis after liver transplantation: a single-center experience","volume":"3","author":"Ueda","year":"2017","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.cellimm.2019.104021_b0445","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","article-title":"Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience","volume":"225","author":"Goss","year":"1997","journal-title":"Ann. Surgery"},{"key":"10.1016\/j.cellimm.2019.104021_b0450","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/S0041-1345(01)02043-7","article-title":"Outcome after liver transplantation for primary sclerosing cholangitis","volume":"33","author":"Liden","year":"2001","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0455","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.3748\/wjg.v24.i43.4939","article-title":"Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease","volume":"24","author":"Bajer","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0460","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0465","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0470","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13317-012-0040-5","article-title":"Recurrence of autoimmune liver diseases after liver transplantation: clinical aspects","volume":"3","author":"Cholongitas","year":"2012","journal-title":"Auto- Immun. Highlig."},{"key":"10.1016\/j.cellimm.2019.104021_b0475","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0480","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0485","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study","volume":"53","author":"Lindstrom","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0490","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Alexander","year":"2008","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0495","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","author":"Brandsaeter","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0500","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","author":"Cholongitas","year":"2008","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0505","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2010.03402.x","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry","volume":"11","author":"Egawa","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0510","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1556\/imas.6.2014.1.2","article-title":"Recurrence of primary sclerosing cholangitis after liver transplantation \u2013 The Hungarian experience","volume":"6","author":"Gelley","year":"2014","journal-title":"Intervent. Med. Appl. Sci."},{"key":"10.1016\/j.cellimm.2019.104021_b0515","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/lt.24496","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0520","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","author":"Jeyarajah","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0525","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s11605-009-0898-3","article-title":"Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis","volume":"13","author":"Kashyap","year":"2009","journal-title":"J. Gastrointest Surg."},{"key":"10.1016\/j.cellimm.2019.104021_b0530","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation\u2013a single-centre experience","volume":"24","author":"Moncrief","year":"2010","journal-title":"J. Can. Gastroenterol."},{"key":"10.1016\/j.cellimm.2019.104021_b0535","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/ajt.13828","article-title":"First-degree living-related donor liver transplantation in autoimmune liver diseases","volume":"16","author":"Aravinthan","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0540","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000760","article-title":"Rituximab induction to prevent the recurrence of PSC after liver transplantation-the lessons learned from ABO-incompatible living donor liver transplantation","volume":"4","author":"Yamada","year":"2018","journal-title":"Transplant. Direct"},{"key":"10.1016\/j.cellimm.2019.104021_b0545","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","article-title":"Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus","volume":"72","author":"Cervera","year":"1993","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cellimm.2019.104021_b0550","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on Lupus Nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0555","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1993.03510110079036","article-title":"Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients","volume":"270","author":"Port","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.cellimm.2019.104021_b0560","doi-asserted-by":"crossref","DOI":"10.7326\/M18-1570","article-title":"Renal transplantation and survival among patients with lupus nephritis: a cohort study","author":"Jorge","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0565","doi-asserted-by":"crossref","unstructured":"Renal transplantation in congenital and metabolic diseases. A report from the ASC\/NIH renal transplant registry, JAMA, 232 (1975) pp. 148-153.","DOI":"10.1001\/jama.1975.03250020022018"},{"key":"10.1016\/j.cellimm.2019.104021_b0570","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1046\/j.1523-1755.2000.00065.x","article-title":"Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis","volume":"57","author":"Ward","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0575","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.tp.0000235740.56573.c6","article-title":"Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database","volume":"82","author":"Bunnapradist","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0580","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1093\/ndt\/gfm459","article-title":"The outcome of renal transplantation among systemic lupus erythematosus patients","volume":"22","author":"Chelamcharla","year":"2007","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0585","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1681\/ASN.2016020126","article-title":"Kidney transplantation outcomes across GN subtypes in the United States","volume":"28","author":"O'Shaughnessy","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0590","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.kint.2016.02.014","article-title":"Long-term outcomes of end-stage kidney disease for patients with lupus nephritis","volume":"89","author":"Zhang","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0595","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1681\/ASN.2009101093","article-title":"Recurrence of lupus nephritis after kidney transplantation","volume":"21","author":"Contreras","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0600","first-page":"1116","article-title":"Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study","volume":"7","author":"Nyberg","year":"1992","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0605","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.TP.0000053750.59630.83","article-title":"Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare","volume":"75","author":"Goral","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0610","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1136\/ard.2009.122796","article-title":"Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study","volume":"69","author":"Norby","year":"2010","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.cellimm.2019.104021_b0615","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trre.2016.10.006","article-title":"Immunosuppression for kidney transplantation: where are we now and where are we going?","volume":"31","author":"Lim","year":"2017","journal-title":"Transplant. Rev. (Orlando)"},{"key":"10.1016\/j.cellimm.2019.104021_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0625","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-6386(12)81017-1","article-title":"Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity","volume":"16","author":"Cheigh","year":"1990","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellimm.2019.104021_b0630","doi-asserted-by":"crossref","unstructured":"D.J. Wallace, in: D.J. Wallace, B.H. Hahn (Eds.) Dubois' Lupus Erythematosus and Related Syndromes (Eighth Edition)2013, pp. 626\u2013632.e612.","DOI":"10.1016\/B978-1-4377-1893-5.00051-0"},{"key":"10.1016\/j.cellimm.2019.104021_b0635","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0961203319842641","article-title":"Renal transplantation for lupus nephritis: non-adherence and graft survival","volume":"28","author":"Ntatsaki","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0640","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.24776","article-title":"Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution","volume":"60","author":"Burgos","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cellimm.2019.104021_b0645","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2005.01.038","article-title":"The long-term prognosis of renal transplantation in patients with lupus nephritis","volume":"45","author":"Moroni","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellimm.2019.104021_b0650","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ki.1997.162","article-title":"Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network","volume":"51","author":"Dooley","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0655","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/art.24091","article-title":"Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus","volume":"61","author":"Hersh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cellimm.2019.104021_b0660","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.transproceed.2008.02.045","article-title":"Systemic lupus erythematosus after renal transplantation: is complement a good marker for graft survival?","volume":"40","author":"Signori Baracat","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0665","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1191\/0961203305lu2067oa","article-title":"Renal transplantation in lupus nephritis","volume":"14","author":"Ponticelli","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0670","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00007890-200004150-00023","article-title":"Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study","volume":"69","author":"Vaidya","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0675","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.1038\/s41598-019-48070-y","article-title":"Outcome and prognosis of patients with lupus nephritis submitted to renal transplantation","volume":"9","author":"Albuquerque","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2019.104021_b0680","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N. Engld. J. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0685","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00007890-199810270-00006","article-title":"Long-term outcome of kidney transplantation in patients with systemic lupus erythematosus: a multicenter study, Groupe Cooperatif de Transplantation d'ile de France","volume":"66","author":"Grimbert","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0690","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2015.08.021","article-title":"An update on liver transplantation: a critical review","volume":"66","author":"Neuberger","year":"2016","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.cellimm.2019.104021_b0695","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0700","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0705","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0710","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0715","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1872-034X.2008.00483.x","article-title":"Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: a blind histologic study","volume":"39","author":"Hytiroglou","year":"2009","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cellimm.2019.104021_b0720","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/lt.21960","article-title":"Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity","volume":"16","author":"Manousou","year":"2010","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0725","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/liv.12027","article-title":"Liver transplantation for overlap syndromes of autoimmune liver diseases","volume":"33","author":"Bhanji","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0730","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2019.104021_b0735","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00268-001-0213-2","article-title":"Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence","volume":"26","author":"Renz","year":"2002","journal-title":"World J. Surg."},{"key":"10.1016\/j.cellimm.2019.104021_b0740","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study","volume":"34","author":"Khettry","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.cellimm.2019.104021_b0745","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl."},{"issue":"Suppl 3","key":"10.1016\/j.cellimm.2019.104021_b0750","first-page":"S449","article-title":"Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan","volume":"37","author":"Yamagiwa","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cellimm.2019.104021_b0755","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl."},{"key":"10.1016\/j.cellimm.2019.104021_b0760","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases\u2013an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J. Gastrointest Surg."},{"key":"10.1016\/j.cellimm.2019.104021_b0765","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007890-198211000-00001","article-title":"Glomerulonephritis in renal transplants","volume":"34","author":"Cameron","year":"1982","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0770","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1001\/archinte.1983.00350110067018","article-title":"Renal transplantation in patients with systemic lupus erythematosus","volume":"143","author":"Mejia","year":"1983","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0775","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM198301273080403","article-title":"The long-term clinical course of systemic lupus erythematosus in end-stage renal disease","volume":"308","author":"Coplon","year":"1983","journal-title":"N. Engld. J. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0780","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archinte.1983.00350070073014","article-title":"The clinical course of end-stage renal disease in systemic lupus erythematosus","volume":"143","author":"Jarrett","year":"1983","journal-title":"Arch. Int. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0785","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJM198301273080411","article-title":"Dialysis and transplantation in end-stage lupus nephritis","volume":"308","author":"Ziff","year":"1983","journal-title":"N. Engld. J. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0790","first-page":"293","article-title":"End-stage renal failure in systemic lupus erythematosus with nephritis","volume":"22","author":"Correia","year":"1984","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0795","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000167615","article-title":"Renal transplantation in systemic lupus erythematosus: one center's experience","volume":"7","author":"Roth","year":"1987","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0800","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00007890-198811000-00015","article-title":"Single-center 1\u201315-year results of renal transplantation in patients with systemic lupus erythematosus","volume":"46","author":"Bumgardner","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0805","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000186123","article-title":"Kidney transplantation in systemic lupus erythematosus nephritis: a one-center experience","volume":"56","author":"Rivera","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.cellimm.2019.104021_b0810","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-114-3-183","article-title":"Systemic lupus erythematosus after renal transplantation: patient and graft survival and disease activity. The dutch working party on systemic lupus erythematosus","volume":"114","author":"Nossent","year":"1991","journal-title":"Ann. Int. Med."},{"key":"10.1016\/j.cellimm.2019.104021_b0815","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00007890-199111000-00009","article-title":"Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature","volume":"52","author":"Goss","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0820","first-page":"1785","article-title":"Renal transplantation in cyclosporine-treated patients with end-stage lupus nephropathy","volume":"24","author":"Sumrani","year":"1992","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0825","first-page":"2172","article-title":"Renal transplantation in patients with systemic lupus erythematosus","volume":"25","author":"Bitker","year":"1993","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000168816","article-title":"Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases","volume":"15","author":"el-Shahawy","year":"1995","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0835","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ki.1996.73","article-title":"Risk factors for renal allograft loss in patients with systemic lupus erythematosus","volume":"49","author":"Lochhead","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0840","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/00007890-199705150-00010","article-title":"Renal transplantation for patients with autoimmune diseases: single-center experience with 42 patients","volume":"63","author":"Haubitz","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2019.104021_b0845","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1016\/S0041-1345(98)01285-8","article-title":"Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis","volume":"30","author":"Uchida","year":"1998","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0850","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0041-1345(98)00437-0","article-title":"Renal transplantation for systemic lupus erythematosis: excellent long-term results with both living and cadaveric donors","volume":"30","author":"Magee","year":"1998","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0855","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1529-0131(199804)41:4<678::AID-ART15>3.0.CO;2-7","article-title":"Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era","volume":"41","author":"Stone","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2019.104021_b0860","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/ndt\/13.11.2894","article-title":"Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients","volume":"13","author":"Azevedo","year":"1998","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0865","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0041-1345(00)01356-7","article-title":"Thirteen-year results of renal transplantation in patients with systemic lupus erythematosus","volume":"32","author":"Tsang","year":"2000","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0870","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1432-2277.2003.tb00322.x","article-title":"Outcome of renal transplantation in patients with systemic lupus erythematosus","volume":"16","author":"Deegens","year":"2003","journal-title":"Transpl. Int."},{"key":"10.1016\/j.cellimm.2019.104021_b0875","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1399-0012.2004.00297.x","article-title":"Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease","volume":"19","author":"Dong","year":"2005","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0880","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.transproceed.2005.02.062","article-title":"Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease","volume":"37","author":"Villaverde Verdejo","year":"2005","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0885","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.transproceed.2006.01.028","article-title":"Recurrent glomerular diseases after renal transplantation","volume":"38","author":"Karakayali","year":"2006","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0890","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0961203308089430","article-title":"Kidney transplantation in lupus patients: a case-control study from a single centre","volume":"17","author":"Lionaki","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0895","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.transproceed.2007.12.013","article-title":"Renal transplantation in patients with lupus nephritis: a single-center experience","volume":"40","author":"Ghafari","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0900","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.2215\/CJN.00190111","article-title":"Graft loss due to recurrent lupus nephritis in living-related kidney donation","volume":"6","author":"Pham","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2019.104021_b0905","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-011-1931-y","article-title":"Impact of recurrent lupus nephritis on lupus kidney transplantation: a 20-year single center experience","volume":"31","author":"Yu","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cellimm.2019.104021_b0910","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1093\/ndt\/gfr731","article-title":"The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence","volume":"27","author":"Pham","year":"2012","journal-title":"Nephrol. Dial Transplant."},{"key":"10.1016\/j.cellimm.2019.104021_b0915","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0961203311430220","article-title":"Renal transplantation in lupus nephritis: a Brazilian cohort","volume":"21","author":"Oliveira","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0920","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.transproceed.2016.02.061","article-title":"Outcomes in renal transplant recipients with lupus nephritis-a single-center experience and review of the literature","volume":"48","author":"Golebiewska","year":"2016","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0925","doi-asserted-by":"crossref","first-page":"51","DOI":"10.25100\/cm.v47i1.2085","article-title":"Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy","volume":"47","author":"Nieto-Rios","year":"2016","journal-title":"Colomb Med. (Cali)"},{"key":"10.1016\/j.cellimm.2019.104021_b0930","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/nep.12657","article-title":"Recurrent lupus nephritis after transplantation: clinicopathological evaluation with protocol biopsies","volume":"21","author":"CeltIk","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cellimm.2019.104021_b0935","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/0961203317696591","article-title":"Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience","volume":"26","author":"Naranjo-Escobar","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0940","first-page":"30640","article-title":"Kidney transplantation in systemic lupus erythematosus: Outcomes and prognosis","author":"Pampa-Saico","year":"2018","journal-title":"Med. Clin. (Barc)"},{"key":"10.1016\/j.cellimm.2019.104021_b0945","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.transproceed.2018.02.039","article-title":"Clinical outcomes of kidney transplantation in patients with biopsy-proven glomerulonephritis","volume":"50","author":"Park","year":"2018","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2019.104021_b0950","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1177\/0961203318770527","article-title":"Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort","volume":"27","author":"Ramirez-Sandoval","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0955","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0961203317725591","article-title":"Renal outcome after kidney-transplantation in Korean patients with lupus nephritis","volume":"27","author":"Park","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2019.104021_b0960","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.reuma.2017.07.006","article-title":"Renal transplantation in systemic lupus erythematosus: comparison of graft survival with other causes of end-stage renal disease","volume":"15","author":"Horta-Baas","year":"2019","journal-title":"Reumatol. Clin."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874919303582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874919303582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:02:11Z","timestamp":1757804531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874919303582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":192,"alternative-id":["S0008874919303582"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2019.104021","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2019.104021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104021"}}